![]() |
Market Research Report
Product code
1071993
Global Implantable Medical Devices Market 2022-2026 |
Global Implantable Medical Devices Market 2022-2026 |
Published: April 21, 2022
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
|
Technavio has been monitoring the implantable medical devices market and it is poised to grow by $ 41.4 bn during 2022-2026, accelerating at a CAGR of 7.27% during the forecast period. Our report on the implantable medical devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising in the number of people with chronic illnesses, product launches by vendors, and an increasing number of cosmetic implants.
The implantable medical devices market analysis includes type segment and geographic landscape.
Technavio's implantable medical devices market is segmented as below:
By Type
By Geography
This study identifies the 3D printing of implantable medical devices as one of the prime reasons driving the implantable medical devices market growth during the next few years. Also, strategic alliances and partnerships and advances in surgical procedures will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on implantable medical devices market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading implantable medical devices market vendors that include Abbott Laboratories, AbbVie Inc., B. Braun SE, BIOTRONIK SE and Co KG, Boston Scientific Corp., Cardinal Health Inc., CEREPLAS Co., Conmed Corp., Global Consolidated Aesthetics Ltd., Globus Medical Inc., Ideal Implant Inc., Johnson and Johnson, LivaNova Plc, Medtronic Plc, Nuvasive Inc., Orthofix Medical Inc., Osstem and Hiossen Implant UK, Smith and Nephew plc, Straumann Holding AG, Stryker Corp., and Zimmer Biomet Holdings Inc. Also, the implantable medical devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: